PNC Financial Services Group’s Vir Biotechnology VIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.3K | Buy |
13,159
+2,700
| +26% | +$13.6K | ﹤0.01% | 2955 |
|
|
2025
Q1 | $67.8K | Buy |
10,459
+2,171
| +26% | +$14.1K | ﹤0.01% | 2915 |
|
|
2024
Q4 | $60.8K | Buy |
8,288
+1,999
| +32% | +$14.7K | ﹤0.01% | 2982 |
|
|
2024
Q3 | $47.1K | Sell |
6,289
-3,430
| -35% | -$25.7K | ﹤0.01% | 3126 |
|
|
2024
Q2 | $86.5K | Sell |
9,719
-5,239
| -35% | -$46.6K | ﹤0.01% | 2710 |
|
|
2024
Q1 | $152K | Buy |
14,958
+3,772
| +34% | +$38.2K | ﹤0.01% | 2364 |
|
|
2023
Q4 | $113K | Buy |
11,186
+1,869
| +20% | +$18.8K | ﹤0.01% | 2527 |
|
|
2023
Q3 | $87.3K | Buy |
9,317
+4,656
| +100% | +$43.6K | ﹤0.01% | 2656 |
|
|
2023
Q2 | $114K | Buy |
4,661
+640
| +16% | +$15.7K | ﹤0.01% | 2566 |
|
|
2023
Q1 | $93.6K | Buy |
4,021
+13
| +0.3% | +$303 | ﹤0.01% | 2610 |
|
|
2022
Q4 | $101K | Buy |
4,008
+2,937
| +274% | +$74.3K | ﹤0.01% | 2550 |
|
|
2022
Q3 | $20K | Sell |
1,071
-3,362
| -76% | -$62.8K | ﹤0.01% | 3458 |
|
|
2022
Q2 | $114K | Buy |
+4,433
| New | +$114K | ﹤0.01% | 2477 |
|
|
2020
Q4 | – | Sell |
-26
| Closed | -$1K | – | 4077 |
|
|
2020
Q3 | $1K | Buy |
+26
| New | +$1K | ﹤0.01% | 3886 |
|
|
2020
Q2 | – | Sell |
-216
| Closed | -$8K | – | 4065 |
|
|
2020
Q1 | $8K | Buy |
+216
| New | +$8K | ﹤0.01% | 3493 |
|